Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache

Mise à jour : Il y a 4 ans
Référence : NCT01540799

Femme et Homme

Extrait

The purpose of the clinical study is to evaluate the use of an implanted sphenopalatine ganglion (SPG) neurostimulator for the treatment of migraine headache pain, migraine headache symptoms and migraine frequency in high disability migraineurs.


Critère d'inclusion

  • High Frequency, High Disability Migraine

Liens